COLL vs SPCE · P/E 17, rev $181.9M vs rev $7.0M
Collegium Pharmaceutical Inc (COLL) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the COLL and SPCE stock pages for the full models.
Not investment advice.